ICD-10-CM Billable Code

H71.1

Cholesteatoma of tympanum

Clinical Classification Guidelines

Medical Intelligence & Overview

Cholesteatoma of the tympanum is a condition characterized by the growth of abnormal skin tissue in the middle ear, specifically within the tympanum or eardrum region. This benign but potentially serious condition can lead to hearing loss, infections, and damage to the middle ear structures if not properly managed. Often developing as a result of chronic ear infections or eustachian tube dysfunction, cholesteatomas require careful diagnosis and management to prevent complications.

Causes & Symptoms

Clinical Causes: Chronic Middle Ear Infections (Otitis Media): Repeated or persistent infections can cause retraction of the eardrum and promote abnormal skin growth. Eustachian Tube Dysfunction: Impaired function can lead to negative pressure in the middle ear, encouraging the development of cholesteatoma. Eardrum Perforation: A tear or rupture may serve as an entry point for skin tissue into the middle ear. Congenital Factors: Some individuals are born with skin remnants in the middle ear which can develop into cholesteatomas over time. Previous Ear Surgery or Trauma: Surgical interventions or injuries may alter ear anatomy, increasing the risk of abnormal skin growth.

Key Symptoms: Persistent or intermittent ear discharge (otorrhea), often foul-smelling. Hearing loss fluctuating or progressive over time. A sensation of fullness or pressure in the ear. Earache or discomfort. Tinnitus (ringing in the ear). Dizziness or balance disturbances if the condition affects nearby structures. In some cases, visible or aural examination reveals a pearly or white mass behind the eardrum.

Diagnostic & Treatment

Diagnosis Path: Diagnosing cholesteatoma involves a combination of clinical examination and diagnostic tests. An otolaryngologist (ENT specialist) typically performs a thorough physical exam of the ear using an otoscope to look for signs such as retracted eardrum, abnormal tissue, or perforation. Additional assessments include: - Audiometry testing to evaluate hearing loss. - Imaging studies like CT scans to determine the extent of the growth and any bone destruction. - Possible biopsy if the mass appears suspicious or atypical. Accurate diagnosis is critical to determine the appropriate treatment plan and prevent complications.

Treatment Protocols: Treatment of cholesteatoma of the tympanum generally involves surgical intervention. The main goals are to remove the abnormal skin tissue, prevent further damage, and restore ear function. Surgical options include: - Mastoidectomy and Middle Ear Surgery: Procedures to excise the cholesteatoma and clean affected areas. - Reconstruction of the eardrum (tympanoplasty) if necessary. - Close monitoring post-surgery to detect any recurrence. In some cases, antibiotics or other medications may be prescribed to manage secondary infections or inflammation before or after surgery. Without appropriate treatment, cholesteatomas can enlarge and lead to complications such as hearing impairment, destructive erosion of bone, or intracranial infections.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H71.1 a billable ICD-10 code?
Yes, H71.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H71.1?
Clinical documentation must specify the nature of Cholesteatoma of tympanum and any associated comorbidities for accurate reporting.

Cite this Clinical Reference